Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors

被引:0
|
作者
Ahmaditaba, Mohammad Ali [1 ]
Tehrani, Mohammad Hassan Houshdar [1 ]
Zarghi, Afshin [1 ]
Shahosseini, Sorayya [1 ]
Daraei, Bahram [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Chem, Tehran, Iran
[2] Tarbiat Modares Univ, Dept Toxicol, Fac Med Sci, Tehran, Iran
来源
关键词
Peptide analogue; Solid phase peptide synthesis; Wang resin; COX-2; enzyme; Inhibitor; CYCLOOXYGENASE-2; INHIBITORS; ANTIINFLAMMATORY DRUGS; MECHANISM; IDENTIFICATION; POTENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO2Me or N-3 attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC50 value of 0.08 mu M and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [41] Design and synthesis of selective COX-2 inhibitors: Identification of Celebrex.
    Miyashiro, JM
    Bertenshaw, SR
    Carter, JS
    Collins, PW
    Docter, S
    Graneto, MJ
    Lee, LF
    Malecha, JW
    Penning, TD
    Rogers, RS
    Rogier, DJ
    Talley, JJ
    Yu, SS
    Anderson, GD
    Burton, EG
    Cogburn, JN
    Gregory, SA
    Isakson, PC
    Koboldt, CM
    Masferrer, JL
    Perkins, WE
    Seibert, K
    Veenhuizen, AW
    Zhang, YY
    Zweifel, BS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U110 - U111
  • [42] Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities
    Wang, Youzhi
    Yang, Guoqing
    Shen, Huizhen
    Liang, Ying
    Dong, Haijuan
    Guo, Ximing
    Hao, Qingjing
    Wang, Jinxin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 266
  • [43] EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
    Musa, Arafa
    Mostafa, Ehab M.
    Bukhari, Syed Nasir Abbas
    Alotaibi, Nasser Hadal
    El-Ghorab, Ahmed H.
    Farouk, Amr
    Nayl, AbdElAziz A.
    Ghoneim, Mohammed M.
    Abdelgawad, Mohamed A.
    MOLECULES, 2022, 27 (04):
  • [44] Design and synthesis of new diaryl sulfonamides as selective COX-2 inhibitors
    Tabaraki, Parisa
    Zarghi, Afshin
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A9 - A10
  • [45] Design and synthesis of novel benzo-dioxolane cyclooxygenase (COX-2) selective inhibitors.
    Ezawa, M
    Khanapure, SP
    Garvey, DS
    Young, D
    Earl, RA
    Gaston, RD
    Fang, XQ
    Marek, P
    Shumway, M
    Trocha, M
    Janero, DR
    Letts, LG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U217 - U218
  • [46] Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors
    Gedawy, Ehab M.
    Kassab, Asmaa E.
    El Kerdawy, Ahmed M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
  • [47] Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety
    Saglik, Begum Nurpelin
    Osmaniye, Derya
    Levent, Serkan
    Cevik, Ulviye Acar
    Cavusoglu, Betul Kaya
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [48] Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents
    Abolhasani, Hoda
    Zarghi, Afshin
    Movahhed, Tahereh Komeili
    Abolhasani, Ahmad
    Daraei, Bahram
    Dastmalchi, Siavoush
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 32
  • [49] Design, Synthesis and Biological Evaluation of New N-Acyl Hydrazones with a Methyl Sulfonyl Moiety as Selective COX-2 Inhibitors
    Osmaniye, Derya
    Saglik, Begum Nurpelin
    Levent, Serkan
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    CHEMISTRY & BIODIVERSITY, 2021, 18 (11)
  • [50] Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors
    Movahed, Mahsa Azami
    Daraei, Bahram
    Shahosseini, Soraya
    Esfahanizadeh, Marjan
    Zarghi, Afshin
    ARCHIV DER PHARMAZIE, 2019, 352 (02)